US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Celcuity Inc

107.90

+1.151.08%

Post-market: 107.900.00000.00%16:20 EST

Volume:500.65K

Turnover:53.96M

Market Cap:4.99B

PE:-29.38

High:110.40

Open:106.68

Low:105.57

Close:106.75

52wk High:120.32

52wk Low:7.58

Shares:46.27M

Float Shares:22.54M

Volume Ratio:0.59

T/O Rate:2.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6721

EPS(LYR):-2.8335

ROE:-122.04%

ROA:-26.60%

PB:42.69

PE(LYR):-38.08

Loading ...

Overview Company News Filings

Is It Too Late To Consider Celcuity (CELC) After An 8x One Year Surge

Simply Wall St.

Celcuity präsentiert sich auf dem Guggenheim Emerging Outlook: Biotech Summit

Celcuity Inc. Director David Dalvey Reports Sale of Common Shares

Assessing Celcuity (CELC) Valuation As Momentum Builds Around Its Clinical Pipeline

Simply Wall St.

FDA Accepts Celcuity New Drug Application for Gedatolisib in Advanced Breast Cancer

Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in Hr+/Her2-/Pik3CA Wild-Type Advanced Breast Cancer

THOMSON REUTERS

Celcuity Inc - FDA Grants Priority Review and Assigns a Pdufa Goal Date of July 17, 2026

THOMSON REUTERS

The Bull Case For Celcuity (CELC) Could Change Following Shelf Registration And FDA Review Progress - Learn Why

Simply Wall St.

Assessing Celcuity (CELC) Valuation After Wells Fargo Coverage And Key FDA NDA Review Progress

Simply Wall St.

BRIEF-Celcuity Files For Mixed Shelf Size Not Disclosed - SEC Filing

Celcuity Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS

Did Gedatolisib’s Phase 3 PFS and Tolerability Data Just Shift Celcuity’s (CELC) Investment Narrative?

Simply Wall St.

Celcuity Reports Positive Phase 3 Results for Gedatolisib in Advanced Breast Cancer Trial

Celcuity Presents Updated Results From the Pik3CA Wild-Type Cohort of the Phase 3 Viktoria-1 Trial at the 2025 San Antonio Breast Cancer Symposium

THOMSON REUTERS

Is Celcuity’s Huge 2025 Rally Justified by Its Long Term Cash Flow Potential?

Simply Wall St.

Celcuity Inc. Director Richard E. Buller Reports Sale of Common Shares

Muling, Heilongjiang: Flax Weaving a Prosperous Industry

Celcuity Is Maintained at Buy by Jefferies

U.S. RESEARCH ROUNDUP- Green Brick Partners, Pultegroup, Toll Brothers

Celcuity Announces Updated Phase 3 VIKTORIA-1 Trial Results for Gedatolisib in HR+/HER2- Advanced Breast Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CELC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CELC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELC\",,,,,undefined,":{"symbol":"CELC","market":"US","secType":"STK","nameCN":"Celcuity Inc","latestPrice":107.9,"timestamp":1770670800000,"preClose":106.75,"halted":0,"volume":500654,"hourTrading":{"tag":"盘后","latestPrice":107.9,"preClose":107.9,"latestTime":"16:20 EST","volume":7259,"amount":783224.068935,"timestamp":1770672000379,"change":0,"changeRate":0,"amplitude":0.001112},"delay":0,"changeRate":0.010772833723653449,"floatShares":22539400,"shares":46271259,"eps":-3.672053,"marketStatus":"Post-Mkt","change":1.15,"latestTime":"02-09 16:48:34 EST","open":106.68,"high":110.4,"low":105.57,"amount":53964423.878587,"amplitude":0.045246,"askPrice":109,"askSize":120,"bidPrice":105.81,"bidSize":18,"shortable":3,"etf":0,"ttmEps":-3.672053,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":106.75,"preHourTrading":{"tag":"盘前","latestPrice":105.09,"preClose":106.75,"latestTime":"08:35 EST","volume":5,"amount":526.6805,"timestamp":1770644145057,"change":-1.66,"changeRate":-0.01555,"amplitude":0.011335},"postHourTrading":{"tag":"盘后","latestPrice":107.9,"preClose":107.9,"latestTime":"16:20 EST","volume":7259,"amount":783224.068935,"timestamp":1770672000379,"change":0,"changeRate":0,"amplitude":0.001112},"volumeRatio":0.592603,"impliedVol":0.7972,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELC\",,,,,undefined,":{"symbol":"CELC","floatShares":22539400,"roa":"-26.60%","roe":"-122.04%","lyrEps":-2.83348,"volumeRatio":0.592603,"shares":46271259,"dividePrice":0,"high":110.4,"amplitude":0.045246,"preClose":106.75,"low":105.57,"week52Low":7.575,"pbRate":"42.69","week52High":120.315,"institutionHeld":0,"latestPrice":107.9,"committee":-0.73913,"eps":-3.672053,"divideRate":0,"volume":500654,"delay":0,"ttmEps":-3.672053,"open":106.68,"prevYearClose":99.74,"prevWeekClose":106.75,"prevMonthClose":109.42,"prevQuarterClose":99.74,"fiveDayClose":111.34,"twentyDayClose":107.51,"sixtyDayClose":79.165},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CELC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"CELC","fiscalQuarterEnding":"2025/09","expectedEps":-1.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-08-14","symbol":"CELC","fiscalQuarterEnding":"2025/06","expectedEps":-0.9,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-1.04},{"market":"US","date":"2025-05-14","symbol":"CELC","fiscalQuarterEnding":"2025/03","expectedEps":-0.95,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.86},{"market":"US","date":"2025-03-31","symbol":"CELC","fiscalQuarterEnding":"2024/12","expectedEps":-0.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2024-11-14","symbol":"CELC","fiscalQuarterEnding":"2024/09","expectedEps":-0.65,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CELC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CELC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.4545,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4545,"analysts":11,"updateTime":1765602000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CELC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CELC","date":"2026-02-06","current":-29.070931,"percent":0.085366,"low":-39.043696,"twenty":-14.615822,"median":-6.529137,"eighty":-4.320343,"high":-2.364134,"avg":-10.086879,"sd":8.893838,"marketCap":4825166888},"quantilePoints":[{"date":"2021-02-12","current":-19.539081,"twenty":-34.517164,"median":-27.632424,"eighty":-11.036796,"marketCap":170621256},{"date":"2021-02-19","current":-19.359235,"twenty":-34.461266,"median":-27.585782,"eighty":-11.199542,"marketCap":183412784},{"date":"2021-02-26","current":-18.012847,"twenty":-34.447291,"median":-27.567066,"eighty":-11.261729,"marketCap":170656863},{"date":"2021-03-05","current":-16.305721,"twenty":-34.406482,"median":-27.436342,"eighty":-11.337629,"marketCap":154483253},{"date":"2021-03-12","current":-17.128457,"twenty":-34.358831,"median":-27.33424,"eighty":-11.429287,"marketCap":162277998},{"date":"2021-03-19","current":-20.121402,"twenty":-34.347117,"median":-27.313278,"eighty":-11.449461,"marketCap":190633685},{"date":"2021-03-26","current":-18.870145,"twenty":-34.315343,"median":-27.278342,"eighty":-11.464139,"marketCap":178779056},{"date":"2021-04-01","current":-19.13058,"twenty":-34.049217,"median":-27.18052,"eighty":-11.474204,"marketCap":181246466},{"date":"2021-04-09","current":-28.014951,"twenty":-33.867015,"median":-27.12812,"eighty":-11.560394,"marketCap":265418553},{"date":"2021-04-16","current":-33.566062,"twenty":-34.323139,"median":-27.208469,"eighty":-11.629114,"marketCap":318010748},{"date":"2021-04-23","current":-32.839749,"twenty":-34.205061,"median":-27.297138,"eighty":-11.652698,"marketCap":311129526},{"date":"2021-04-30","current":-35.874702,"twenty":-34.411786,"median":-27.330573,"eighty":-11.704582,"marketCap":339883203},{"date":"2021-05-07","current":-35.200268,"twenty":-34.533934,"median":-27.3954,"eighty":-11.747032,"marketCap":333493497},{"date":"2021-05-14","current":-33.969151,"twenty":-34.47524,"median":-27.562804,"eighty":-11.783372,"marketCap":340331765},{"date":"2021-05-21","current":-35.938378,"twenty":-34.533934,"median":-27.583038,"eighty":-11.851351,"marketCap":360061143},{"date":"2021-05-28","current":-34.19637,"twenty":-34.573181,"median":-27.603219,"eighty":-11.913891,"marketCap":342608232},{"date":"2021-06-04","current":-33.943905,"twenty":-34.542318,"median":-27.683604,"eighty":-11.935702,"marketCap":340078824},{"date":"2021-06-11","current":-33.956528,"twenty":-34.542318,"median":-27.823252,"eighty":-12.021782,"marketCap":340205295},{"date":"2021-06-18","current":-32.883552,"twenty":-34.489215,"median":-27.865273,"eighty":-12.169181,"marketCap":329455313},{"date":"2021-06-25","current":-37.667762,"twenty":-34.542318,"median":-27.901307,"eighty":-12.224399,"marketCap":377387584},{"date":"2021-07-02","current":-36.131699,"twenty":-34.652079,"median":-27.92536,"eighty":-12.264739,"marketCap":361997999},{"date":"2021-07-09","current":-36.979233,"twenty":-34.786234,"median":-27.962831,"eighty":-12.28426,"marketCap":370489310},{"date":"2021-07-16","current":-31.358746,"twenty":-34.810608,"median":-28.028622,"eighty":-12.318917,"marketCap":314178510},{"date":"2021-07-23","current":-31.670995,"twenty":-34.806645,"median":-28.107483,"eighty":-12.409654,"marketCap":317306888},{"date":"2021-07-30","current":-29.291953,"twenty":-34.786234,"median":-28.137783,"eighty":-12.452238,"marketCap":293471628},{"date":"2021-08-06","current":-31.00189,"twenty":-34.722557,"median":-28.194831,"eighty":-12.454756,"marketCap":310603221},{"date":"2021-08-13","current":-14.543553,"twenty":-34.684581,"median":-28.137783,"eighty":-12.471051,"marketCap":317772425},{"date":"2021-08-20","current":-14.523088,"twenty":-34.667774,"median":-28.107483,"eighty":-12.51895,"marketCap":317325278},{"date":"2021-08-27","current":-15.109742,"twenty":-34.604727,"median":-28.028622,"eighty":-12.650323,"marketCap":330143490},{"date":"2021-09-03","current":-14.666341,"twenty":-34.601786,"median":-27.962831,"eighty":-12.879418,"marketCap":320455307},{"date":"2021-09-10","current":-14.448051,"twenty":-34.59432,"median":-27.92536,"eighty":-12.948109,"marketCap":315685739},{"date":"2021-09-17","current":-14.038758,"twenty":-34.559088,"median":-27.901307,"eighty":-12.967998,"marketCap":306742800},{"date":"2021-09-24","current":-12.29244,"twenty":-34.517164,"median":-27.865273,"eighty":-12.948109,"marketCap":268586261},{"date":"2021-10-01","current":-12.087793,"twenty":-34.447291,"median":-27.823252,"eighty":-12.524373,"marketCap":264114792},{"date":"2021-10-08","current":-11.6785,"twenty":-34.447291,"median":-27.683604,"eighty":-12.452185,"marketCap":255171853},{"date":"2021-10-15","current":-12.415228,"twenty":-34.435045,"median":-27.5945,"eighty":-12.399021,"marketCap":271269143},{"date":"2021-10-22","current":-11.965005,"twenty":-34.398342,"median":-27.580294,"eighty":-12.29244,"marketCap":261431910},{"date":"2021-10-29","current":-12.347012,"twenty":-34.39628,"median":-27.51717,"eighty":-12.265154,"marketCap":269778653},{"date":"2021-11-05","current":-12.920023,"twenty":-34.349469,"median":-27.389654,"eighty":-12.278797,"marketCap":282298768},{"date":"2021-11-12","current":-10.2625,"twenty":-34.346529,"median":-27.325419,"eighty":-12.149187,"marketCap":260694779},{"date":"2021-11-19","current":-9.437851,"twenty":-34.307546,"median":-27.287985,"eighty":-12.033221,"marketCap":239746514},{"date":"2021-11-26","current":-8.962141,"twenty":-34.218605,"median":-27.208469,"eighty":-11.981377,"marketCap":227662215},{"date":"2021-12-03","current":-7.640725,"twenty":-34.155976,"median":-27.12812,"eighty":-11.899831,"marketCap":194094719},{"date":"2021-12-10","current":-7.828659,"twenty":-34.138565,"median":-27.082698,"eighty":-11.75958,"marketCap":198868763},{"date":"2021-12-17","current":-7.628979,"twenty":-34.093556,"median":-27.022174,"eighty":-11.675226,"marketCap":193796342},{"date":"2021-12-23","current":-8.210402,"twenty":-34.075187,"median":-26.915004,"eighty":-11.593992,"marketCap":208566040},{"date":"2021-12-31","current":-7.746438,"twenty":-34.054989,"median":-26.831156,"eighty":-11.451985,"marketCap":196780119},{"date":"2022-01-07","current":-7.441044,"twenty":-34.007021,"median":-26.757897,"eighty":-11.319998,"marketCap":189022298},{"date":"2022-01-14","current":-6.771526,"twenty":-33.974201,"median":-26.64135,"eighty":-11.032226,"marketCap":172014767},{"date":"2022-01-21","current":-6.460259,"twenty":-33.964102,"median":-26.529889,"eighty":-10.89402,"marketCap":164107757},{"date":"2022-01-28","current":-6.060898,"twenty":-33.956528,"median":-26.430782,"eighty":-10.695515,"marketCap":153962913},{"date":"2022-02-04","current":-6.378038,"twenty":-33.951479,"median":-26.146402,"eighty":-10.580908,"marketCap":162019112},{"date":"2022-02-11","current":-6.689305,"twenty":-33.917142,"median":-26.0366,"eighty":-10.457417,"marketCap":169926122},{"date":"2022-02-18","current":-6.019787,"twenty":-33.870343,"median":-25.92749,"eighty":-10.375303,"marketCap":152918591},{"date":"2022-02-25","current":-6.560099,"twenty":-33.854347,"median":-25.786504,"eighty":-10.32796,"marketCap":166643967},{"date":"2022-03-04","current":-5.403126,"twenty":-33.830296,"median":-25.436641,"eighty":-10.098757,"marketCap":137253760},{"date":"2022-03-11","current":-5.17408,"twenty":-33.825247,"median":-24.898286,"eighty":-9.794564,"marketCap":131435394},{"date":"2022-03-18","current":-4.7571,"twenty":-33.788162,"median":-24.700905,"eighty":-9.564803,"marketCap":120842984},{"date":"2022-03-25","current":-4.208188,"twenty":-33.718237,"median":-24.588115,"eighty":-9.452014,"marketCap":124584521},{"date":"2022-04-01","current":-4.616407,"twenty":-33.695876,"median":-24.510572,"eighty":-9.296689,"marketCap":136669966},{"date":"2022-04-08","current":-3.830207,"twenty":-33.644388,"median":-24.390733,"eighty":-9.176972,"marketCap":113394295},{"date":"2022-04-14","current":-4.026757,"twenty":-33.644117,"median":-24.248802,"eighty":-9.056614,"marketCap":119213212},{"date":"2022-04-22","current":-3.432067,"twenty":-33.615701,"median":-24.158105,"eighty":-8.986948,"marketCap":101607256},{"date":"2022-04-29","current":-3.285914,"twenty":-33.594843,"median":-24.052365,"eighty":-8.88362,"marketCap":97280369},{"date":"2022-05-06","current":-3.245596,"twenty":-33.566062,"median":-23.960724,"eighty":-8.621509,"marketCap":96086744},{"date":"2022-05-13","current":-2.696264,"twenty":-33.538945,"median":-23.88318,"eighty":-8.485351,"marketCap":79823615},{"date":"2022-05-20","current":-2.450103,"twenty":-33.439875,"median":-23.573009,"eighty":-8.359952,"marketCap":85136283},{"date":"2022-05-27","current":-2.811171,"twenty":-33.421308,"median":-23.403825,"eighty":-8.262419,"marketCap":97682682},{"date":"2022-06-03","current":-3.120657,"twenty":-33.390581,"median":-23.34743,"eighty":-8.162243,"marketCap":108436739},{"date":"2022-06-10","current":-3.314086,"twenty":-33.369874,"median":-23.227591,"eighty":-7.961557,"marketCap":115158024},{"date":"2022-06-17","current":-3.653662,"twenty":-33.353813,"median":-23.051358,"eighty":-7.856874,"marketCap":126957615},{"date":"2022-06-24","current":-3.87718,"twenty":-33.306354,"median":-22.839877,"eighty":-7.828659,"marketCap":134724433},{"date":"2022-07-01","current":-3.907269,"twenty":-33.245368,"median":-22.670693,"eighty":-7.745876,"marketCap":135769967},{"date":"2022-07-08","current":-4.054812,"twenty":-33.181092,"median":-22.593151,"eighty":-7.725721,"marketCap":140896779},{"date":"2022-07-15","current":-4.007513,"twenty":-33.112726,"median":-22.48741,"eighty":-7.705089,"marketCap":139253232},{"date":"2022-07-22","current":-4.080611,"twenty":-33.080044,"median":-22.282979,"eighty":-7.678311,"marketCap":141793259},{"date":"2022-07-29","current":-3.904315,"twenty":-33.033239,"median":-22.205436,"eighty":-7.637182,"marketCap":135667312},{"date":"2022-08-05","current":-4.493402,"twenty":-33.022452,"median":-21.930512,"eighty":-7.600718,"marketCap":156136940},{"date":"2022-08-12","current":-5.065566,"twenty":-33.010062,"median":-21.881166,"eighty":-7.552108,"marketCap":155389873},{"date":"2022-08-19","current":-4.890219,"twenty":-32.995872,"median":-21.697883,"eighty":-7.500948,"marketCap":150010993},{"date":"2022-08-26","current":-4.83177,"twenty":-32.984328,"median":-20.517804,"eighty":-7.48733,"marketCap":148218033},{"date":"2022-09-02","current":-4.641812,"twenty":-32.968344,"median":-20.068879,"eighty":-7.446342,"marketCap":142390913},{"date":"2022-09-09","current":-4.388533,"twenty":-32.961267,"median":-19.916061,"eighty":-7.416525,"marketCap":134621419},{"date":"2022-09-16","current":-4.320343,"twenty":-32.941513,"median":-19.793952,"eighty":-7.371038,"marketCap":132529632},{"date":"2022-09-23","current":-4.320343,"twenty":-32.888577,"median":-19.515947,"eighty":-7.294118,"marketCap":132529632},{"date":"2022-09-30","current":-4.890219,"twenty":-32.811244,"median":-19.058971,"eighty":-7.238465,"marketCap":150010993},{"date":"2022-10-07","current":-4.890219,"twenty":-32.717228,"median":-18.676634,"eighty":-7.198004,"marketCap":150010993},{"date":"2022-10-14","current":-5.036341,"twenty":-32.623788,"median":-18.482086,"eighty":-7.173037,"marketCap":154493393},{"date":"2022-10-21","current":-4.919444,"twenty":-32.5169,"median":-18.223224,"eighty":-7.115612,"marketCap":150907473},{"date":"2022-10-28","current":-4.987634,"twenty":-32.396656,"median":-18.012847,"eighty":-7.053924,"marketCap":152999260},{"date":"2022-11-04","current":-4.865866,"twenty":-32.344227,"median":-17.67597,"eighty":-7.006482,"marketCap":149263926},{"date":"2022-11-11","current":-4.501925,"twenty":-32.304464,"median":-17.491238,"eighty":-6.986458,"marketCap":160008298},{"date":"2022-11-18","current":-4.332287,"twenty":-32.203543,"median":-17.128457,"eighty":-6.966626,"marketCap":153979000},{"date":"2022-11-25","current":-3.914718,"twenty":-32.172963,"median":-16.862333,"eighty":-6.928359,"marketCap":139137651},{"date":"2022-12-02","current":-3.588491,"twenty":-32.030877,"median":-16.235489,"eighty":-6.853632,"marketCap":127542846},{"date":"2022-12-09","current":-4.080006,"twenty":-31.925763,"median":-15.918986,"eighty":-6.827243,"marketCap":145012351},{"date":"2022-12-16","current":-4.354036,"twenty":-31.793604,"median":-15.526576,"eighty":-6.77505,"marketCap":154751987},{"date":"2022-12-23","current":-5.598046,"twenty":-31.677324,"median":-15.40989,"eighty":-6.743824,"marketCap":198966840},{"date":"2022-12-30","current":-8.540783,"twenty":-31.642388,"median":-15.345873,"eighty":-6.721133,"marketCap":303558172},{"date":"2023-01-06","current":-7.333735,"twenty":-31.604313,"median":-15.290272,"eighty":-6.690425,"marketCap":260657017},{"date":"2023-01-13","current":-7.102079,"twenty":-31.544568,"median":-15.16517,"eighty":-6.679908,"marketCap":252423462},{"date":"2023-01-20","current":-6.888712,"twenty":-31.453461,"median":-15.081768,"eighty":-6.663464,"marketCap":244839925},{"date":"2023-01-27","current":-6.346149,"twenty":-31.353855,"median":-15.026167,"eighty":-6.641238,"marketCap":225556072},{"date":"2023-02-03","current":-5.955992,"twenty":-31.324045,"median":-14.984467,"eighty":-6.602687,"marketCap":211689032},{"date":"2023-02-10","current":-7.163041,"twenty":-31.312235,"median":-14.928866,"eighty":-6.594178,"marketCap":254590187},{"date":"2023-02-17","current":-7.041117,"twenty":-31.264859,"median":-14.850523,"eighty":-6.594178,"marketCap":250256737},{"date":"2023-02-24","current":-7.13256,"twenty":-31.212082,"median":-14.803763,"eighty":-6.594178,"marketCap":253506825},{"date":"2023-03-03","current":-6.986251,"twenty":-31.170088,"median":-14.666341,"eighty":-6.594178,"marketCap":248306685},{"date":"2023-03-10","current":-6.907,"twenty":-31.161084,"median":-14.543553,"eighty":-6.594178,"marketCap":245489942},{"date":"2023-03-17","current":-6.266899,"twenty":-31.161084,"median":-14.400656,"eighty":-6.535132,"marketCap":222739330},{"date":"2023-03-24","current":-5.109394,"twenty":-31.161084,"median":-14.108751,"eighty":-6.463783,"marketCap":206266431},{"date":"2023-03-31","current":-5.50697,"twenty":-31.160356,"median":-14.035056,"eighty":-6.429018,"marketCap":222316606},{"date":"2023-04-06","current":-5.318927,"twenty":-31.160356,"median":-13.934998,"eighty":-6.402225,"marketCap":214725307},{"date":"2023-04-14","current":-5.238337,"twenty":-31.161084,"median":-13.820468,"eighty":-6.35842,"marketCap":211471893},{"date":"2023-04-21","current":-5.265201,"twenty":-31.161084,"median":-13.761245,"eighty":-6.280725,"marketCap":212556365},{"date":"2023-04-28","current":-5.383399,"twenty":-31.161084,"median":-13.622242,"eighty":-6.179646,"marketCap":217328038},{"date":"2023-05-05","current":-5.238337,"twenty":-31.15605,"median":-13.48324,"eighty":-6.074993,"marketCap":211471893},{"date":"2023-05-12","current":-5.227592,"twenty":-31.109205,"median":-13.377067,"eighty":-5.9822,"marketCap":211038105},{"date":"2023-05-19","current":-4.84632,"twenty":-31.109205,"median":-13.206862,"eighty":-5.909586,"marketCap":215050648},{"date":"2023-05-26","current":-5.062401,"twenty":-31.109205,"median":-13.159939,"eighty":-5.806002,"marketCap":224639025},{"date":"2023-06-02","current":-5.596848,"twenty":-31.109205,"median":-13.056454,"eighty":-5.634584,"marketCap":248354582},{"date":"2023-06-09","current":-5.41375,"twenty":-31.109205,"median":-12.967998,"eighty":-5.55801,"marketCap":240229808},{"date":"2023-06-16","current":-5.285087,"twenty":-31.109205,"median":-12.858629,"eighty":-5.50697,"marketCap":234520507},{"date":"2023-06-23","current":-5.90366,"twenty":-31.067231,"median":-12.511862,"eighty":-5.501514,"marketCap":261969068},{"date":"2023-06-30","current":-5.418699,"twenty":-30.897652,"median":-12.415228,"eighty":-5.48581,"marketCap":240449396},{"date":"2023-07-07","current":-4.844663,"twenty":-30.782862,"median":-12.298891,"eighty":-5.429792,"marketCap":214977131},{"date":"2023-07-14","current":-4.780332,"twenty":-30.745204,"median":-12.265154,"eighty":-5.405712,"marketCap":212122481},{"date":"2023-07-21","current":-5.319727,"twenty":-30.621806,"median":-12.108258,"eighty":-5.387164,"marketCap":236057626},{"date":"2023-07-28","current":-4.884252,"twenty":-30.510267,"median":-11.98547,"eighty":-5.368841,"marketCap":216733839},{"date":"2023-08-04","current":-5.012915,"twenty":-30.398832,"median":-11.884711,"eighty":-5.320222,"marketCap":222443140},{"date":"2023-08-11","current":-4.481291,"twenty":-30.285517,"median":-11.732882,"eighty":-5.265201,"marketCap":219588490},{"date":"2023-08-18","current":-4.300713,"twenty":-30.266197,"median":-11.614964,"eighty":-5.230353,"marketCap":210739964},{"date":"2023-08-25","current":-4.580214,"twenty":-30.170926,"median":-11.449878,"eighty":-5.201804,"marketCap":224435852},{"date":"2023-09-01","current":-4.291697,"twenty":-30.050273,"median":-11.253666,"eighty":-5.184611,"marketCap":210298161},{"date":"2023-09-08","current":-4.039244,"twenty":-30.037185,"median":-11.012873,"eighty":-5.17408,"marketCap":197927681},{"date":"2023-09-15","current":-4.44948,"twenty":-29.955129,"median":-10.784366,"eighty":-5.095183,"marketCap":218029711},{"date":"2023-09-22","current":-4.481036,"twenty":-29.805184,"median":-10.58488,"eighty":-5.065566,"marketCap":219576021},{"date":"2023-09-29","current":-4.2376,"twenty":-29.716796,"median":-10.443076,"eighty":-5.041212,"marketCap":207647344},{"date":"2023-10-06","current":-4.093341,"twenty":-29.342214,"median":-10.339762,"eighty":-5.017864,"marketCap":200578498},{"date":"2023-10-13","current":-4.156454,"twenty":-29.258974,"median":-10.109523,"eighty":-5.007966,"marketCap":203671118},{"date":"2023-10-20","current":-4.517101,"twenty":-28.690165,"median":-9.729675,"eighty":-4.953532,"marketCap":221343232},{"date":"2023-10-27","current":-4.688408,"twenty":-28.518135,"median":-9.558211,"eighty":-4.94081,"marketCap":229737487},{"date":"2023-11-03","current":-4.539641,"twenty":-28.26009,"median":-9.437851,"eighty":-4.921202,"marketCap":222447740},{"date":"2023-11-10","current":-4.70644,"twenty":-28.101933,"median":-9.201365,"eighty":-4.914573,"marketCap":230621092},{"date":"2023-11-17","current":-5.237908,"twenty":-27.935673,"median":-9.056614,"eighty":-4.907793,"marketCap":296004597},{"date":"2023-11-24","current":-5.884616,"twenty":-27.866534,"median":-8.986948,"eighty":-4.907793,"marketCap":332551363},{"date":"2023-12-01","current":-6.28292,"twenty":-27.629095,"median":-8.868174,"eighty":-4.907793,"marketCap":355060298},{"date":"2023-12-08","current":-6.622921,"twenty":-27.354205,"median":-8.561833,"eighty":-4.908429,"marketCap":374274438},{"date":"2023-12-15","current":-6.609523,"twenty":-26.439819,"median":-8.468812,"eighty":-4.908429,"marketCap":373517308},{"date":"2023-12-22","current":-6.538069,"twenty":-25.195398,"median":-8.285581,"eighty":-4.908429,"marketCap":369479283},{"date":"2023-12-29","current":-6.524671,"twenty":-24.703724,"median":-8.195173,"eighty":-4.907793,"marketCap":368722154},{"date":"2024-01-05","current":-6.270115,"twenty":-24.53172,"median":-8.07432,"eighty":-4.907156,"marketCap":354336690},{"date":"2024-01-12","current":-6.435353,"twenty":-24.348437,"median":-7.86149,"eighty":-4.907156,"marketCap":363674622},{"date":"2024-01-19","current":-6.587194,"twenty":-24.052365,"median":-7.828659,"eighty":-4.90652,"marketCap":372255426},{"date":"2024-01-26","current":-6.538069,"twenty":-23.928296,"median":-7.745736,"eighty":-4.907156,"marketCap":369479283},{"date":"2024-02-02","current":-6.801557,"twenty":-23.392546,"median":-7.710069,"eighty":-4.907156,"marketCap":384369500},{"date":"2024-02-09","current":-6.462149,"twenty":-23.009062,"median":-7.686496,"eighty":-4.907156,"marketCap":365188882},{"date":"2024-02-16","current":-7.087374,"twenty":-22.639676,"median":-7.637764,"eighty":-4.907156,"marketCap":400521600},{"date":"2024-02-23","current":-6.698841,"twenty":-22.391539,"median":-7.61276,"eighty":-4.907156,"marketCap":378564840},{"date":"2024-03-01","current":-6.948931,"twenty":-22.199797,"median":-7.552536,"eighty":-4.907793,"marketCap":392697927},{"date":"2024-03-08","current":-8.011814,"twenty":-21.768377,"median":-7.552536,"eighty":-4.907793,"marketCap":452763548},{"date":"2024-03-15","current":-7.953757,"twenty":-20.253558,"median":-7.552536,"eighty":-4.907793,"marketCap":449482653},{"date":"2024-03-22","current":-7.868905,"twenty":-19.843993,"median":-7.552536,"eighty":-4.907793,"marketCap":444687498},{"date":"2024-03-28","current":-7.185986,"twenty":-19.529395,"median":-7.551823,"eighty":-4.907793,"marketCap":458315832},{"date":"2024-04-05","current":-9.501811,"twenty":-19.049947,"median":-7.534607,"eighty":-4.907156,"marketCap":606017088},{"date":"2024-04-12","current":-9.40154,"twenty":-18.66107,"median":-7.534607,"eighty":-4.907156,"marketCap":599621932},{"date":"2024-04-19","current":-7.825863,"twenty":-18.482086,"median":-7.534607,"eighty":-4.907156,"marketCap":499126636},{"date":"2024-04-26","current":-7.529827,"twenty":-18.22617,"median":-7.529827,"eighty":-4.907793,"marketCap":480245702},{"date":"2024-05-03","current":-8.43226,"twenty":-18.03761,"median":-7.529827,"eighty":-4.907793,"marketCap":537802099},{"date":"2024-05-10","current":-8.284242,"twenty":-17.739646,"median":-7.529827,"eighty":-4.907793,"marketCap":528361632},{"date":"2024-05-17","current":-7.508504,"twenty":-17.495951,"median":-7.515085,"eighty":-4.907793,"marketCap":551523301},{"date":"2024-05-24","current":-6.743198,"twenty":-17.181036,"median":-7.490118,"eighty":-4.907793,"marketCap":495309148},{"date":"2024-05-31","current":-7.215894,"twenty":-16.897625,"median":-7.480247,"eighty":-4.907793,"marketCap":530030158},{"date":"2024-06-07","current":-6.857488,"twenty":-16.277628,"median":-7.426424,"eighty":-4.907793,"marketCap":503704157},{"date":"2024-06-14","current":-7.330583,"twenty":-15.960904,"median":-7.379671,"eighty":-4.907156,"marketCap":538454478},{"date":"2024-06-21","current":-7.440494,"twenty":-15.609978,"median":-7.330079,"eighty":-4.90652,"marketCap":546527785},{"date":"2024-06-28","current":-7.775006,"twenty":-15.429274,"median":-7.317504,"eighty":-4.90266,"marketCap":571098720},{"date":"2024-07-05","current":-7.794121,"twenty":-15.347093,"median":-7.317504,"eighty":-4.90266,"marketCap":572502773},{"date":"2024-07-12","current":-8.17642,"twenty":-15.290272,"median":-7.317504,"eighty":-4.90266,"marketCap":600583841},{"date":"2024-07-15","current":-8.491817,"twenty":-15.286276,"median":-7.317504,"eighty":-4.90266,"marketCap":623750722},{"date":"2024-08-02","current":-8.573055,"twenty":-15.041338,"median":-7.240448,"eighty":-4.899788,"marketCap":629717949},{"date":"2024-08-09","current":-7.83713,"twenty":-15.012267,"median":-7.240448,"eighty":-4.899788,"marketCap":575661894},{"date":"2024-08-16","current":-7.070618,"twenty":-14.943418,"median":-7.227964,"eighty":-4.899788,"marketCap":583943119},{"date":"2024-08-23","current":-7.568586,"twenty":-14.862144,"median":-7.227964,"eighty":-4.899788,"marketCap":625069016},{"date":"2024-08-30","current":-7.223337,"twenty":-14.812103,"median":-7.223337,"eighty":-4.899788,"marketCap":596555797},{"date":"2024-09-06","current":-7.035019,"twenty":-14.695341,"median":-7.202997,"eighty":-4.899788,"marketCap":581003131},{"date":"2024-09-13","current":-6.568708,"twenty":-14.610582,"median":-7.181329,"eighty":-4.899788,"marketCap":542491770},{"date":"2024-09-20","current":-6.810831,"twenty":-14.506323,"median":-7.168106,"eighty":-4.899788,"marketCap":562488054},{"date":"2024-09-27","current":-6.384874,"twenty":-14.27731,"median":-7.15608,"eighty":-4.899788,"marketCap":527309407},{"date":"2024-10-04","current":-6.644932,"twenty":-14.057602,"median":-7.13256,"eighty":-4.899788,"marketCap":548786897},{"date":"2024-10-11","current":-6.501452,"twenty":-13.983756,"median":-7.126464,"eighty":-4.899788,"marketCap":536937247},{"date":"2024-10-18","current":-6.927409,"twenty":-13.859339,"median":-7.11554,"eighty":-4.899788,"marketCap":572115894},{"date":"2024-10-25","current":-7.08434,"twenty":-13.769157,"median":-7.102079,"eighty":-4.899788,"marketCap":585076449},{"date":"2024-10-31","current":-7.111243,"twenty":-13.677444,"median":-7.093308,"eighty":-4.899788,"marketCap":587298258},{"date":"2024-11-08","current":-7.052954,"twenty":-13.547034,"median":-7.085604,"eighty":-4.899616,"marketCap":582484338},{"date":"2024-11-15","current":-5.574894,"twenty":-13.407324,"median":-7.068148,"eighty":-4.899616,"marketCap":523898035},{"date":"2024-11-22","current":-5.029652,"twenty":-13.246935,"median":-7.041117,"eighty":-4.899616,"marketCap":472659247},{"date":"2024-11-29","current":-5.05731,"twenty":-13.191521,"median":-7.035657,"eighty":-4.899616,"marketCap":475258316},{"date":"2024-12-06","current":-4.986191,"twenty":-13.089591,"median":-7.022224,"eighty":-4.899616,"marketCap":468574996},{"date":"2024-12-13","current":-4.98224,"twenty":-12.971026,"median":-7.007134,"eighty":-4.899616,"marketCap":468203701},{"date":"2024-12-20","current":-4.741228,"twenty":-12.863527,"median":-6.990839,"eighty":-4.897495,"marketCap":445554672},{"date":"2024-12-27","current":-5.167938,"twenty":-12.63637,"median":-6.986251,"eighty":-4.897495,"marketCap":485654592},{"date":"2025-01-03","current":-5.187693,"twenty":-12.457061,"median":-6.979427,"eighty":-4.897495,"marketCap":487511070},{"date":"2025-01-10","current":-5.017799,"twenty":-12.347012,"median":-6.966626,"eighty":-4.896693,"marketCap":471545361},{"date":"2025-01-17","current":-4.444901,"twenty":-12.27988,"median":-6.948931,"eighty":-4.890219,"marketCap":417707505},{"date":"2025-01-24","current":-4.606893,"twenty":-12.182408,"median":-6.928359,"eighty":-4.884691,"marketCap":432930622},{"date":"2025-01-31","current":-4.630599,"twenty":-12.019578,"median":-6.904272,"eighty":-4.870736,"marketCap":435158396},{"date":"2025-02-07","current":-4.974338,"twenty":-11.936881,"median":-6.887055,"eighty":-4.870736,"marketCap":467461110},{"date":"2025-02-14","current":-4.986191,"twenty":-11.78493,"median":-6.855147,"eighty":-4.870736,"marketCap":468574996},{"date":"2025-02-21","current":-5.187693,"twenty":-11.707151,"median":-6.851835,"eighty":-4.870736,"marketCap":487511070},{"date":"2025-02-28","current":-3.753472,"twenty":-11.528936,"median":-6.839942,"eighty":-4.849913,"marketCap":352730782},{"date":"2025-03-07","current":-3.943121,"twenty":-11.473508,"median":-6.828258,"eighty":-4.827874,"marketCap":370552968},{"date":"2025-03-14","current":-3.962876,"twenty":-11.473508,"median":-6.804773,"eighty":-4.802879,"marketCap":372409446},{"date":"2025-03-21","current":-4.136721,"twenty":-11.473508,"median":-6.797925,"eighty":-4.78031,"marketCap":388746451},{"date":"2025-03-28","current":-4.164378,"twenty":-11.473508,"median":-6.789727,"eighty":-4.74942,"marketCap":391345520},{"date":"2025-04-04","current":-2.995896,"twenty":-11.473508,"median":-6.760334,"eighty":-4.729082,"marketCap":334878619},{"date":"2025-04-11","current":-2.928193,"twenty":-11.468478,"median":-6.744933,"eighty":-4.707712,"marketCap":327310740},{"date":"2025-04-17","current":-3.381808,"twenty":-11.468478,"median":-6.743198,"eighty":-4.684909,"marketCap":378015526},{"date":"2025-04-25","current":-3.737254,"twenty":-11.473508,"median":-6.723397,"eighty":-4.625295,"marketCap":417746887},{"date":"2025-05-02","current":-3.656009,"twenty":-11.473508,"median":-6.698841,"eighty":-4.582017,"marketCap":408665433},{"date":"2025-05-09","current":-3.564609,"twenty":-11.473508,"median":-6.694314,"eighty":-4.540543,"marketCap":398448797},{"date":"2025-05-16","current":-3.132599,"twenty":-11.473508,"median":-6.689607,"eighty":-4.518664,"marketCap":398354086},{"date":"2025-05-23","current":-3.201087,"twenty":-11.439666,"median":-6.662876,"eighty":-4.502626,"marketCap":407063348},{"date":"2025-05-30","current":-3.221931,"twenty":-11.053198,"median":-6.647296,"eighty":-4.497975,"marketCap":409713993},{"date":"2025-06-06","current":-3.507796,"twenty":-10.801327,"median":-6.616222,"eighty":-4.484638,"marketCap":446065697},{"date":"2025-06-13","current":-3.740061,"twenty":-10.636513,"median":-6.600591,"eighty":-4.462066,"marketCap":475601456},{"date":"2025-06-20","current":-3.516729,"twenty":-10.518323,"median":-6.591304,"eighty":-4.454079,"marketCap":447201687},{"date":"2025-06-27","current":-3.576284,"twenty":-10.467984,"median":-6.571845,"eighty":-4.444901,"marketCap":454774959},{"date":"2025-07-03","current":-4.106324,"twenty":-10.467984,"median":-6.551467,"eighty":-4.417244,"marketCap":522177076},{"date":"2025-07-11","current":-4.055703,"twenty":-10.467984,"median":-6.535132,"eighty":-4.388533,"marketCap":515739795},{"date":"2025-07-18","current":-4.094413,"twenty":-10.467984,"median":-6.515739,"eighty":-4.349686,"marketCap":520662422},{"date":"2025-07-25","current":-4.183746,"twenty":-10.467984,"median":-6.475546,"eighty":-4.332287,"marketCap":532022329},{"date":"2025-08-01","current":-12.550828,"twenty":-10.801327,"median":-6.466469,"eighty":-4.320343,"marketCap":1596014873},{"date":"2025-08-08","current":-14.177165,"twenty":-11.060154,"median":-6.466469,"eighty":-4.320343,"marketCap":1802826452},{"date":"2025-08-15","current":-14.804119,"twenty":-11.453389,"median":-6.466469,"eighty":-4.320343,"marketCap":2201522033},{"date":"2025-08-22","current":-14.373318,"twenty":-11.6785,"median":-6.466469,"eighty":-4.320343,"marketCap":2137457700},{"date":"2025-08-29","current":-15.577276,"twenty":-11.781603,"median":-6.466469,"eighty":-4.320343,"marketCap":2316498420},{"date":"2025-09-05","current":-15.540188,"twenty":-11.944392,"median":-6.471007,"eighty":-4.320343,"marketCap":2310982948},{"date":"2025-09-12","current":-16.38467,"twenty":-12.033221,"median":-6.501452,"eighty":-4.320343,"marketCap":2436566012},{"date":"2025-09-19","current":-15.699955,"twenty":-12.204556,"median":-6.515739,"eighty":-4.320343,"marketCap":2334741906},{"date":"2025-09-26","current":-14.818384,"twenty":-12.298891,"median":-6.515739,"eighty":-4.320343,"marketCap":2203643369},{"date":"2025-10-03","current":-14.099432,"twenty":-12.463976,"median":-6.515739,"eighty":-4.320343,"marketCap":2096728057},{"date":"2025-10-10","current":-14.113697,"twenty":-12.694912,"median":-6.515739,"eighty":-4.320343,"marketCap":2098849393},{"date":"2025-10-17","current":-14.986709,"twenty":-12.90118,"median":-6.515739,"eighty":-4.320343,"marketCap":2228675128},{"date":"2025-10-24","current":-20.133487,"twenty":-12.994609,"median":-6.524671,"eighty":-4.320343,"marketCap":2994052995},{"date":"2025-10-31","current":-22.527138,"twenty":-13.143684,"median":-6.529137,"eighty":-4.320343,"marketCap":3350013100},{"date":"2025-11-07","current":-21.169119,"twenty":-13.206862,"median":-6.529137,"eighty":-4.320343,"marketCap":3148061956},{"date":"2025-11-14","current":-26.758964,"twenty":-13.525983,"median":-6.529137,"eighty":-4.320343,"marketCap":3979328274},{"date":"2025-11-21","current":-26.72961,"twenty":-13.72852,"median":-6.529137,"eighty":-4.320343,"marketCap":4349498346},{"date":"2025-11-28","current":-28.759923,"twenty":-13.821454,"median":-6.529137,"eighty":-4.320343,"marketCap":4679875135},{"date":"2025-12-05","current":-30.104934,"twenty":-13.984185,"median":-6.529137,"eighty":-4.320343,"marketCap":4898738190},{"date":"2025-12-12","current":-28.65471,"twenty":-14.042373,"median":-6.529137,"eighty":-4.320343,"marketCap":4662754769},{"date":"2025-12-19","current":-28.196895,"twenty":-14.110844,"median":-6.529137,"eighty":-4.320343,"marketCap":4588258042},{"date":"2025-12-26","current":-29.177928,"twenty":-14.161142,"median":-6.529137,"eighty":-4.320343,"marketCap":4747893885},{"date":"2026-01-02","current":-28.361822,"twenty":-14.284334,"median":-6.529137,"eighty":-4.320343,"marketCap":4615095372},{"date":"2026-01-09","current":-29.763705,"twenty":-14.503965,"median":-6.529137,"eighty":-4.320343,"marketCap":4843212679},{"date":"2026-01-16","current":-29.937163,"twenty":-14.615822,"median":-6.529137,"eighty":-4.320343,"marketCap":4871438147},{"date":"2026-01-23","current":-31.498286,"twenty":-14.615822,"median":-6.529137,"eighty":-4.320343,"marketCap":5125467359},{"date":"2026-01-30","current":-31.882168,"twenty":-14.615822,"median":-6.529137,"eighty":-4.320343,"marketCap":5187933559},{"date":"2026-02-06","current":-29.652805,"twenty":-14.615822,"median":-6.529137,"eighty":-4.320343,"marketCap":4825166888}],"updateTime":1770631248765},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CELC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609526849","title":"Is It Too Late To Consider Celcuity (CELC) After An 8x One Year Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526849","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609526849?lang=en_us&edition=fundamental","pubTime":"2026-02-07 23:12","pubTimestamp":1770477131,"startTime":"0","endTime":"0","summary":"If you are looking at Celcuity and wondering whether the current share price still offers value, this article will walk through what the numbers are actually saying about the stock.\nAfter a very large 1 year return of around 8x and a 6.2% gain year to date, the share price has recently seen a 2.4% 7 day decline and a 2.2% 30 day decline, which may have some investors reassessing the balance between potential and risk.\nRecent news around Celcuity has largely focused on its position as a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/is-it-too-late-to-consider-celcuity-celc-after-an-8x-one-yea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/is-it-too-late-to-consider-celcuity-celc-after-an-8x-one-yea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CELC","BK4139","DCF"],"gpt_icon":0},{"id":"2608366456","title":"Celcuity präsentiert sich auf dem Guggenheim Emerging Outlook: Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2608366456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608366456?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:05","pubTimestamp":1770206718,"startTime":"0","endTime":"0","summary":"Celcuity Inc. wird am 11. und 12. Februar 2026 am Guggenheim Emerging Outlook: Biotech Summit 2026 in New York teilnehmen. CEO Brian Sullivan hlt am 11. Februar um 9:30 Uhr ET eine Fireside-Chat-Prsentation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate this news brief via GlobeNewswire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL7sJjZ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","BK4585","BK4588","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","CELC","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014039.USD","BK4112","SG9999014021.USD","SG9999014005.SGD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2607305164","title":"Celcuity Inc. Director David Dalvey Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2607305164","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607305164?lang=en_us&edition=fundamental","pubTime":"2026-01-30 05:32","pubTimestamp":1769722368,"startTime":"0","endTime":"0","summary":"David Dalvey, Director, reported a disposal of common shares of Celcuity Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDL4xJCd2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Celcuity Inc. Director David Dalvey Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2605458906","title":"Assessing Celcuity (CELC) Valuation As Momentum Builds Around Its Clinical Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2605458906","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605458906?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:21","pubTimestamp":1769030474,"startTime":"0","endTime":"0","summary":"Event driven context for Celcuity\nCelcuity (CELC) has been drawing attention after its recent trading performance, with the stock last closing at $105.39 and showing double digit total returns over the past year and the past 3 months.\nSee our latest analysis for Celcuity.\nThat backdrop sits alongside a 50.47% 3 month share price return and very large 1 year total shareholder return, suggesting momentum has been building as investors reassess Celcuity’s growth prospects and risk profile around...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/assessing-celcuity-celc-valuation-as-momentum-builds-around","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/assessing-celcuity-celc-valuation-as-momentum-builds-around","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CELC","DCF","BK4139"],"gpt_icon":0},{"id":"2604181321","title":"FDA Accepts Celcuity New Drug Application for Gedatolisib in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604181321","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604181321?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:30","pubTimestamp":1768912225,"startTime":"0","endTime":"0","summary":"Celcuity Inc. announced that the U.S. Food and Drug Administration  has accepted for filing its New Drug Application  for gedatolisib, a multi-target PI3K/AKT/mTOR inhibitor, for the treatment of hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative , PIK3CA wild-type advanced breast cancer. The FDA granted Priority Review and assigned a Prescription Drug User Fee Act  goal date of July 17, 2026. The NDA submission is based on clinical data from the PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 clinical trial. Gedatolisib has previously received Breakthrough Therapy and Fast Track designations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1WY1z3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","BK4139","LU2210150020.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","NDAQ","BK4588","LU2210149790.SGD","SG9999014005.SGD","LU0314104364.USD","CELC","SG9999014021.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2604118691","title":"Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in Hr+/Her2-/Pik3CA Wild-Type Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2604118691","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604118691?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:30","pubTimestamp":1768912209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2604118625","title":"Celcuity Inc - FDA Grants Priority Review and Assigns a Pdufa Goal Date of July 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604118625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604118625?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:30","pubTimestamp":1768912209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0IL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2603500508","title":"The Bull Case For Celcuity (CELC) Could Change Following Shelf Registration And FDA Review Progress - Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2603500508","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603500508?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:23","pubTimestamp":1768274601,"startTime":"0","endTime":"0","summary":"In early January 2026, Celcuity Inc. filed an omnibus shelf registration covering common and preferred stock, warrants, debt securities and units, shortly after Wells Fargo began coverage and the FDA accepted its NDA under the real-time oncology review program for its PIK3CA asset.\nThis combination of new financing flexibility and a major regulatory milestone for Celcuity’s lead oncology candidate has sharpened investor focus on how the company might fund and advance its development...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/the-bull-case-for-celcuity-celc-could-change-following-shelf","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/the-bull-case-for-celcuity-celc-could-change-following-shelf","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","LU2065732104.USD","CELC","BK4097","PRGS"],"gpt_icon":0},{"id":"2602520593","title":"Assessing Celcuity (CELC) Valuation After Wells Fargo Coverage And Key FDA NDA Review Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2602520593","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602520593?lang=en_us&edition=fundamental","pubTime":"2026-01-12 10:13","pubTimestamp":1768184034,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) is back in focus after Wells Fargo initiated research coverage and the company filed an omnibus shelf registration covering common and preferred stock, warrants, debt securities, and units.\nSee our latest analysis for Celcuity.\nThose catalysts come on top of a 126.77% 90 day share price return and a very large 1 year total shareholder return, suggesting momentum has been building as investors reassess Celcuity’s prospects and risk profile.\nIf this kind of biotech story has...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/assessing-celcuity-celc-valuation-after-wells-fargo-coverage","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/assessing-celcuity-celc-valuation-after-wells-fargo-coverage","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0211328371.USD","LU0648001328.SGD","LU1814569148.SGD","LU0640476718.USD","BK4207","LU0980610538.SGD","LU0683600562.USD","LU0256863811.USD","LU0149725797.USD","CELC","LU0130517989.USD","LU1267930573.SGD","IE00B7SZLL34.SGD","LU0130102774.USD","BK4585","LU0868494617.USD","LU1668664300.SGD","LU2065732104.USD","LU2361045086.USD","LU0154236417.USD","LU0211327993.USD","LU1894683264.USD","IE000M9KFDE8.USD","LU1506573853.SGD","LU1363072403.SGD","LU1074936037.SGD","LU0128525689.USD","IE0002270589.USD","LU1267930227.SGD","IE00B19Z3581.USD","BK4559","LU0289960550.SGD","LU0310800965.SGD","LU0310799852.SGD","LU0070302665.USD","LU0787776722.HKD","DCF","LU2361044865.SGD","LU1894683348.USD","LU0048573561.USD","LU0128525929.USD","LU0175139822.USD","LU1069347547.HKD","PRGS","LU0971096721.USD","BK4097","LU0742534661.SGD","LU1267930490.SGD","LU1035773651.USD","LU2236285917.USD"],"gpt_icon":0},{"id":"2602302593","title":"BRIEF-Celcuity Files For Mixed Shelf Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602302593","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602302593?lang=en_us&edition=fundamental","pubTime":"2026-01-10 06:48","pubTimestamp":1767998930,"startTime":"0","endTime":"0","summary":"BRIEF-Celcuity Files For Mixed Shelf Size Not Disclosed - SEC FilingJan 9 (Reuters) - Celcuity Inc CELC.O:CELCUITY INC FILES FOR MIXED SHELF; SIZE NOT DISCLOSED - SEC FILINGSource text: [ID:n0001493152-26-001112]Further company coverage: CELC.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"2602230162","title":"Celcuity Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602230162","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602230162?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:31","pubTimestamp":1767994302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3YA1MS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2591262060","title":"Did Gedatolisib’s Phase 3 PFS and Tolerability Data Just Shift Celcuity’s (CELC) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2591262060","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591262060?lang=en_us&edition=fundamental","pubTime":"2025-12-16 03:24","pubTimestamp":1765826696,"startTime":"0","endTime":"0","summary":"Celcuity Inc. recently reported updated Phase 3 VIKTORIA-1 results for its PAM inhibitor gedatolisib in HR+/HER2-, PIK3CA wild-type advanced breast cancer, highlighting substantial progression-free survival benefits over fulvestrant in multiple patient sub-groups and geographies.\nAn interesting feature of the data is the combination of extended progression-free survival with stable glucose levels and manageable stomatitis, underscoring a differentiated tolerability profile versus many...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/did-gedatolisibs-phase-3-pfs-and-tolerability-data-just-shif","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/did-gedatolisibs-phase-3-pfs-and-tolerability-data-just-shif","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PFS","BK4195","BK4139","BK4211","CELC"],"gpt_icon":0},{"id":"2590546894","title":"Celcuity Reports Positive Phase 3 Results for Gedatolisib in Advanced Breast Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2590546894","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590546894?lang=en_us&edition=fundamental","pubTime":"2025-12-12 03:35","pubTimestamp":1765481714,"startTime":"0","endTime":"0","summary":"Celcuity Inc., a clinical-stage biotechnology company, announced updated results from the randomized, Phase 3 VIKTORIA-1 trial evaluating gedatolisib, a pan-PI3K and mTORC1/2 inhibitor, in adults with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative , PIK3CA wild-type advanced breast cancer. The data were presented at the 2025 San Antonio Breast Cancer Symposium. Results showed that, for patients whose time to progression on prior therapy exceeded 18 months, the median progression-free survival  was 12.4 months for the gedatolisib triplet , 10.0 months for the gedatolisib doublet , and 1.9 months for fulvestrant alone. Among patients in the U.S., Canada, Western Europe, and Asia Pacific, the median PFS was 16.6 months with the triplet regimen and 7.1 months with the doublet, compared to 1.9 months for fulvestrant. Measures to mitigate stomatitis were generally effective, with most patients experiencing resolution to a lower grade within two weeks.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL25pc6L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014013.SGD","SG9999014021.USD","LU2210149790.SGD","LU2210150020.SGD","CELC","BK4585","IE00BGHQF748.EUR","BK4588","LU2095319765.USD","BK4139","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00B3QW5Z07.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2590546882","title":"Celcuity Presents Updated Results From the Pik3CA Wild-Type Cohort of the Phase 3 Viktoria-1 Trial at the 2025 San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2590546882","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590546882?lang=en_us&edition=fundamental","pubTime":"2025-12-12 03:35","pubTimestamp":1765481700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA6FRZ0N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"2590627195","title":"Is Celcuity’s Huge 2025 Rally Justified by Its Long Term Cash Flow Potential?","url":"https://stock-news.laohu8.com/highlight/detail?id=2590627195","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590627195?lang=en_us&edition=fundamental","pubTime":"2025-12-11 12:50","pubTimestamp":1765428638,"startTime":"0","endTime":"0","summary":"Wondering if Celcuity at around $101 a share is still a smart buy after its huge run, or if you are late to the party? This breakdown will help you decide whether the current price matches the underlying value.\nThe stock has climbed 1.8% over the last week, 32.8% in the last month, and an eye catching 675.6% year to date. Its 1 year gain of 692.5% and 3 year return of 881.0% show just how dramatically market expectations have shifted.\nRecent news flow around Celcuity has centered on growing...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/is-celcuitys-huge-2025-rally-justified-by-its-long-term-cash","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-celc/celcuity/news/is-celcuitys-huge-2025-rally-justified-by-its-long-term-cash","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","DCF","CELC"],"gpt_icon":0},{"id":"2590324550","title":"Celcuity Inc. Director Richard E. Buller Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590324550","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590324550?lang=en_us&edition=fundamental","pubTime":"2025-12-10 05:24","pubTimestamp":1765315447,"startTime":"0","endTime":"0","summary":"Richard E. Buller, Director of Celcuity Inc., reported a disposal of common shares of Celcuity Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDLb7Pvlq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Celcuity Inc. Director Richard E. Buller Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"1119526407","title":"Muling, Heilongjiang: Flax Weaving a Prosperous Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1119526407","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119526407?lang=en_us&edition=fundamental","pubTime":"2025-12-08 07:30","pubTimestamp":1765150245,"startTime":"0","endTime":"0","summary":"Workers at a flax textile company in Muling City, Heilongjiang Province, are busy with production. Since October, Heilongjiang Hongdoushan Flax Textile Co., Ltd. in Muling has been operating at full...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"2588370470","title":"Celcuity Is Maintained at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2588370470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588370470?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:52","pubTimestamp":1764676320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CELC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 06:52 ET (11:52 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2588708783","title":"U.S. RESEARCH ROUNDUP- Green Brick Partners, Pultegroup, Toll Brothers","url":"https://stock-news.laohu8.com/highlight/detail?id=2588708783","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588708783?lang=en_us&edition=fundamental","pubTime":"2025-12-02 15:06","pubTimestamp":1764659172,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Green Brick Partners, Pultegroup, Toll BrothersDec 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nL8N3X8089:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHM","CELC","LU0757428866.USD","TKO","LU2112291526.USD","LU1988902786.USD","LEN","FTRE","BK4096","ICFI","LU1057294990.SGD","CRL","LU0345770308.USD","EPR","ULTA","DE","LU2211817866.USD","ROK","LU1917777945.USD","LU0432979614.USD","LU1064131342.USD","KBH","NVR","BV","IE0004445239.USD","LU0882574139.USD","IQV","ACAD","LU0079474960.USD","LU0980610538.SGD","LU0823417737.USD","BK4123","DFH","GRBK","LU2108987350.USD","MRP","MDB","BK4120","LU1868837300.USD","FWONA","CF","LU0211331839.USD","SDHC","TOL","EOLS","LU2211815571.USD","DHI","LU0456855351.SGD","FWONK"],"gpt_icon":1},{"id":"2586260920","title":"Celcuity Announces Updated Phase 3 VIKTORIA-1 Trial Results for Gedatolisib in HR+/HER2- Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260920?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:05","pubTimestamp":1764191120,"startTime":"0","endTime":"0","summary":"Celcuity Inc. announced that updated data from the PIK3CA wild-type cohort of its Phase 3 VIKTORIA-1 clinical trial will be presented at the 2025 San Antonio Breast Cancer Symposium , scheduled for December 9-12, 2025. The presentation will cover additional sub-group efficacy analyses and safety data regarding gedatolisib, a multi-target PI3K/AKT/mTOR inhibitor, in combination with fulvestrant with or without palbociclib for the second-line treatment of patients with HR+/HER2-/PIK3CA-wild type advanced breast cancer. The abstract is currently available on the SABCS website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celcuity Inc. published the original content used to generate this news brief via GlobeNewswire  on November 26, 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL5psnbD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU2210150020.SGD","LU2095319765.USD","BK4139","CELC","IE00B64PRP62.GBP","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","LU0314104364.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":110,"code":"91000000","status":"200"}]}}